Altimmune to Test Obesity Drug for Alcohol Use Disorder and Related Health Conditions

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver...
Reuters Health Information

source https://www.medscape.com/s/viewarticle/altimmune-test-obesity-drug-alcohol-use-disorder-and-related-2025a100066m?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost